Correlation of Mast Cell Density With Angiogenic Cytokines in Patients With Active Multiple Myeloma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical Therapeutics

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clinthera.2015.11.022PMID 26740291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis.

  2016cited by this paper
• The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis

  2015cited by this paper
• Mast Cells, Mastocytosis, and Related Disorders.

  2015cited by this paper
• The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling

  2014cited by this paper
• Angiogenesis in multiple myeloma.

  2014cited by this paper
• Circulating Levels of Soluble Angiogenic Factors in Multiple Myeloma: Correlation with Parameters of Disease Activity and Prognosis

  2014cited by this paper
• The role of inflammatory cells in angiogenesis in multiple myeloma.

  2014cited by this paper
• Positive correlation between bone marrow mast cell density and ISS prognostic index in patients with multiple myeloma.

  2013cited by this paper
• Bone marrow angiogenesis and progression in multiple myeloma.

  2011cited by this paper
• Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment.

  2011cited by this paper
• IL-33 augments substance P–induced VEGF secretion from human mast cells and is increased in psoriatic skin

  2010cited by this paper
• Human mast cells synthesize and release angiogenin, a member of the ribonuclease A (RNase A) superfamily

  2009cited by this paper
• Mast Cells Contribute to Vasculogenic Mimicry in Multiple Myeloma

  2008cited by this paper
• Anti-Chemokine Therapy for Inflammatory Diseases

  2007cited by this paper
• Human Mast Cell-Derived Gelatinase B (Matrix Metalloproteinase-9) Is Regulated by Inflammatory Cytokines: Role in Cell Migration1

  2006cited by this paper
• Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9–mediated progenitor cell mobilization

  2005cited by this paper
• Mast cells: the Jekyll and Hyde of tumor growth.

  2004cited by this paper
• Human Mast Cells Release Metalloproteinase-9 on Contact with Activated T Cells: Juxtacrine Regulation by TNF-α1

  2001cited by this paper
• Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-kit receptor activation.

  1999cited by this paper
• Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma

  1999cited by this paper
• Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma.

  1999cited by this paper
• Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells.

  1997cited by this paper
• Bone marrow angiogenesis and progression in multiple myeloma

  1994cited by this paper

• Bone marrow mast cells and mast cell tryptase in plasma cell disorders

  2025cites this paper
• A Fully Human IgE Specific for CD38 as a Potential Therapy for Multiple Myeloma

  2023cites this paper
• Identification of a novel cuproptosis‐related gene signature for multiple myeloma diagnosis

  2023cites this paper
• Steering Mast Cells or Their Mediators as a Prospective Novel Therapeutic Approach for the Treatment of Hematological Malignancies

  2021cites this paper
• Targeting the Tumor Microenvironment for a More Effective and Efficient Cancer Immunotherapy

  2020cites this paper
• Mast Cells and Angiogenesis in Human Plasma Cell Malignancies

  2019cites this paper
• Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy

  2018cites this paper